Table 1. Use of outpatient physiotherapy/occupational therapy, antispasticity drugs and analgesics over a 2-year-old follow-up observation period after the diagnosis of.
| PSS patients, n (%) | 7947 (100) | ||
| n (%) | Prescriptions per patient median (IQR) | Treatment units per patient median (IQR) | |
| Physiotherapy | |||
| – at least one prescription – regular prescriptions – regular PSS-specific prescriptions |
6021 (75.8) 3488 (43.9) 1985 (25.0) |
7 (2–12) 11 (8–15) 10 (7–14) |
51 (18–110) 100 (66–140) 92 (66–132) |
| Occupational therapy | |||
| – at least one prescription – regular prescriptions – regular PSS-specific prescriptions |
3426 (43.1) 1978 (24.9) 1302 (16.4) |
6 (2–10) 10 (7–10) 9 (6–13) |
54 (21–101) 91 (66–131) 87 (61–124) |
| n (%) | Prescriptions per patient median (IQR) | Prescribed DDD per patient median (IQR) | |
| Antispasticity drugs and analgesics | |||
| – at least one prescription for oral antispasticity drugs – at least one prescription for BoNT-A – regular prescriptions for analgesics |
815 (10.3) 80 (1) 708 (8.9) |
3 (1–11) 3 (1–5) 23 (16–31) |
92 (20–400) not defined 317 (236–454) |
Treatment unit data were retrieved from billing information submitted by therapists.
Regular pain medication was regarded to be the prescription of more than 180 DDDs during the follow-up observation period.
BoNT-A, botulinum toxin type A; DDD, defined daily dose; IQR, interquartile range; PSS, post-stroke spasticity